Treatment for basal cell carcinoma

  • US 7,696,159 B2
  • Filed: 01/15/2008
  • Issued: 04/13/2010
  • Est. Priority Date: 03/25/2003
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method of treating a patient diagnosed with superficial basal cell carcinoma for six weeks, the method comprising:

  • applying an effective amount of 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine (imiquimod) to a treatment area of the patient in accordance with a six-week treatment cycle for treating superficial basal cell carcinoma;

    wherein, the treatment area comprises a biopsy-confirmed superficial basal cell carcinoma lesion and about one centimeter of extramarginal skin that surrounds and extends beyond the lesion;

    wherein, the six-week treatment cycle comprises applying the imiquimod to the treatment area in accordance with a seven-day treatment regimen for six consecutive weeks;

    wherein, the seven-day treatment regimen comprises (a) applying the imiquimod to the treatment area once per day prior to sleeping hours for five consecutive days and (b) not applying the imiquimod to the treatment area for two consecutive days; and

    wherein, the imiquimod, once applied to the treatment area, is left on the treatment area for about 8 hours.

View all claims

    Thank you for your feedback